Stanmore Implants Worldwide designs and manufactures implant systems used primarily in limb salvage for adult and juvenile oncology patients.
The first commercial test for the Zika virus has been cleared for emergency use in the U.S. and could be available by next week.
Medical technology can spot disease, but often only when a patient already is in imminent danger. What if a simple handheld device could scan the body to detect disease much sooner?
Greenway Health co-founder Tee Green is stepping down from the top office at the Carrollton, Ga.-based electronic health record and practice management company. He will stay on full time as executive chairman to focus on innovation and growth initiatives. Scott Zimmerman will replace him as CEO.
The Food and Drug Administration has approved the first pacemaker to do away with electrical wires that have long been a shortcoming of internal heart devices.
Senators have advanced the bipartisan legislation to foster biomedical innovations, but it won't make it to the Senate floor without an agreement on funding for the National Institutes of Health.
Patients with pacemakers, drug pumps and other medical devices face a very small risk of electrical malfunction when undergoing medical scanning, but it shouldn't stop them from getting necessary care, according to health regulators.
Ann Arbor, Mich.-based Hygieia, a medical device company, has teamed up with Blue Cross and Blue Shield of Michigan to launch a demonstration project to help about 1,000 diabetic patients more effectively manage their disease.
Omron Healthcare, a $7 billion heart health technology manufacturer and distributor, named Ranndy Kellogg president and CEO, giving him responsibility for operations in the U.S. and Canada.
The sequencing of the human genome—an achievement that capped a 13-year, $3 billion international effort funded by the federal government—represents the most significant breakthrough in healthcare over the past 40 years, according to Modern Healthcare readers.
A software designer is suing a California company, claiming its medical device used to treat aneurysms malfunctioned and caused him to suffer brain damage.
A disappearing medical implant will get a closer look from the Food and Drug Administration this week. The FDA meets on Tuesday to review Abbott Laboratories' first-of-a-kind heart stent that dissolves into the body after helping to clear fat-clogged arteries.